ArcticZymes Technologies ASA (LON:0DRV)

Market Cap	89.27M +75.1%
Revenue (ttm)	8.19M -0.7%
Net Income	536.28K +55.6%
EPS	0.01 +75.1%
Shares Out	n/a
PE Ratio	166.45
Forward PE	55.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13
Average Volume	2,265
Open	22.00
Previous Close	n/a
Day's Range	22.00 - 22.00
52-Week Range	14.50 - 31.00
Beta	0.35
RSI	44.74
Earnings Date	Feb 12, 2026

About LON:0DRV

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 53
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2024, LON:0DRV's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.

Financial numbers in NOK